PSMA3

proteasome 20S subunit alpha 3, the group of Proteasome

Basic information

Region (hg38): 14:58244843-58272012

Links

ENSG00000100567NCBI:5684OMIM:176843HGNC:9532Uniprot:P25788AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Proteasome-associated autoinflammatory syndrome 2DigenicAllergy/Immunology/InfectiousIndividuals may have recurrent infections, and awareness may allow preventative measures as well as prompt and agressive treatment of infectionsAllergy/Immunology/Infectious; Cardiovascular; Dermatologic; Endocrine; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic26524591
Digenic inheritance has been reported

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PSMA3 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PSMA3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
37
clinvar
1
clinvar
39
missense
52
clinvar
52
nonsense
0
start loss
0
frameshift
0
inframe indel
2
clinvar
2
splice donor/acceptor (+/-2bp)
0
splice region
12
15
4
31
non coding
3
clinvar
50
clinvar
5
clinvar
58
Total 0 0 58 87 6

Variants in PSMA3

This is a list of pathogenic ClinVar variants found in the PSMA3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
14-58244926-C-T Likely benign (Jul 26, 2023)2991385
14-58244929-A-G Likely benign (Sep 07, 2022)2013481
14-58244935-C-T Likely benign (May 12, 2023)3023948
14-58244938-T-C Likely benign (Dec 08, 2021)2180139
14-58244953-G-C Likely benign (Dec 08, 2023)2701239
14-58247736-C-T Likely benign (Jan 31, 2024)1655302
14-58247743-C-T Likely benign (Sep 18, 2023)2894199
14-58247752-T-C Likely benign (Aug 31, 2022)2029786
14-58247763-C-T Uncertain significance (Jun 19, 2022)2008426
14-58247764-C-G Likely benign (Jul 29, 2021)1548767
14-58247767-T-C Likely benign (Aug 10, 2023)1652715
14-58247779-T-C Likely benign (Feb 10, 2021)1562200
14-58247782-C-T Likely benign (Oct 11, 2022)1555770
14-58247810-A-G Uncertain significance (Oct 30, 2022)3002023
14-58247822-G-A Uncertain significance (Feb 19, 2022)1966344
14-58247843-T-C Likely benign (Jun 25, 2023)2728811
14-58247846-AACCAGGTATT-A Likely benign (Jul 17, 2023)2002595
14-58247847-A-G Likely benign (Nov 29, 2022)3006447
14-58252100-TTTC-T Likely benign (May 04, 2022)2088626
14-58252101-T-A Likely benign (Aug 17, 2023)1634552
14-58252104-T-C Likely benign (Aug 10, 2023)1653110
14-58252105-TCTC-T Likely benign (Dec 27, 2023)1641448
14-58252108-CCTT-C Likely benign (Jul 26, 2023)1545897
14-58252141-A-G Uncertain significance (Apr 22, 2022)1977476
14-58252151-T-C not specified Uncertain significance (May 14, 2024)3310951

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PSMA3protein_codingprotein_codingENST00000216455 1127182
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9850.0154125629031256320.0000119
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.76791370.5770.000006851675
Missense in Polyphen838.5950.20728461
Synonymous0.1114647.00.9790.00000261462
Loss of Function3.61117.10.05858.18e-7223

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.00004630.0000462
European (Non-Finnish)0.00001770.0000176
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Component of the 20S core proteasome complex involved in the proteolytic degradation of most intracellular proteins. This complex plays numerous essential roles within the cell by associating with different regulatory particles. Associated with two 19S regulatory particles, forms the 26S proteasome and thus participates in the ATP-dependent degradation of ubiquitinated proteins. The 26S proteasome plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins that could impair cellular functions, and by removing proteins whose functions are no longer required. Associated with the PA200 or PA28, the 20S proteasome mediates ubiquitin-independent protein degradation. This type of proteolysis is required in several pathways including spermatogenesis (20S-PA200 complex) or generation of a subset of MHC class I-presented antigenic peptides (20S-PA28 complex). Binds to the C-terminus of CDKN1A and thereby mediates its degradation. Negatively regulates the membrane trafficking of the cell-surface thromboxane A2 receptor (TBXA2R) isoform 2. {ECO:0000269|PubMed:11350925, ECO:0000269|PubMed:14550573, ECO:0000269|PubMed:15244466, ECO:0000269|PubMed:17499743, ECO:0000269|PubMed:27176742}.;
Pathway
Proteasome - Homo sapiens (human);Proteasome Degradation;TLR NFkB;proteasome complex;B cell receptor signaling;Post-translational protein modification;Metabolism of proteins;DroToll-like;Notch;Hedgehog;IL-1 NFkB;IL-1 p38;IL-1 JNK;TGF-beta super family signaling pathway canonical;TLR p38;UCH proteinases;Neddylation;Ub-specific processing proteases;JAK STAT pathway and regulation;Deubiquitination;TLR JNK;TNF;Wnt Canonical;Aurora B signaling;Wnt Mammals;CD4 T cell receptor signaling-NFkB cascade;CD4 T cell receptor signaling (Consensus)

Recessive Scores

pRec
0.400

Intolerance Scores

loftool
rvis_EVS
-0.32
rvis_percentile_EVS
31.46

Haploinsufficiency Scores

pHI
0.994
hipred
Y
hipred_score
0.831
ghis
0.702

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.845

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumLowLow
Primary ImmunodeficiencyMediumLowMedium
CancerMediumLowMedium

Mouse Genome Informatics

Gene name
Psma3
Phenotype

Gene ontology

Biological process
proteasomal protein catabolic process;proteasomal ubiquitin-independent protein catabolic process;viral process;protein deubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;post-translational protein modification;regulation of endopeptidase activity
Cellular component
proteasome complex;nucleus;nucleoplasm;cytoplasm;cytosol;proteasome core complex;proteasome core complex, alpha-subunit complex;synapse;extracellular exosome
Molecular function
endopeptidase activity;threonine-type endopeptidase activity;protein binding;ubiquitin protein ligase binding